等温滴定量热法
生物化学
生物
精氨酸
交易激励
辅因子
结合位点
转录因子
血浆蛋白结合
化学
立体化学
酶
氨基酸
基因
作者
John S. Sack,Sandrine Thieffine,Tiziano Bandiera,Marina Fasolini,Gerald J. Duke,Lata Jayaraman,Kevin Kish,Herbert E. Klei,Ashok V. Purandare,Pamela Rosettani,Sonia Troiani,Dianlin Xie,Jay Aaron Bertrand
摘要
CARM1 (co-activator-associated arginine methyltransferase 1) is a PRMT (protein arginine N-methyltransferase) family member that catalyses the transfer of methyl groups from SAM (S-adenosylmethionine) to the side chain of specific arginine residues of substrate proteins. This post-translational modification of proteins regulates a variety of transcriptional events and other cellular processes. Moreover, CARM1 is a potential oncological target due to its multiple roles in transcription activation by nuclear hormone receptors and other transcription factors such as p53. Here, we present crystal structures of the CARM1 catalytic domain in complex with cofactors [SAH (S-adenosyl-L-homocysteine) or SNF (sinefungin)] and indole or pyazole inhibitors. Analysis of the structures reveals that the inhibitors bind in the arginine-binding cavity and the surrounding pocket that exists at the interface between the N- and C-terminal domains. In addition, we show using ITC (isothermal titration calorimetry) that the inhibitors bind to the CARM1 catalytic domain only in the presence of the cofactor SAH. Furthermore, sequence differences for select residues that interact with the inhibitors may be responsible for the CARM1 selectivity against PRMT1 and PRMT3. Together, the structural and biophysical information should aid in the design of both potent and specific inhibitors of CARM1.
科研通智能强力驱动
Strongly Powered by AbleSci AI